EcoDrugPlus

60s Ribosomal Protein L19

Ensembl ID : ENSOTSG00005043259
Gene Symbol: LOC112223774
3 Cross references
344 Possible Orthologues:

60s Ribosomal Protein L22

Ensembl ID : ENSOTSG00005011271
Gene Symbol: LOC112218418
2 Cross references
197 Possible Orthologues:

60s Ribosomal Protein L22-Like

Ensembl ID : ENSOTSG00005041933
Gene Symbol: LOC112215872
3 Cross references
159 Possible Orthologues:

60s Ribosomal Protein L22-Like

Ensembl ID : ENSOTSG00005034709
Gene Symbol: LOC112215872
3 Cross references
159 Possible Orthologues:

60s Ribosomal Protein L23a-Like

Ensembl ID : ENSOTSG00005024606
Gene Symbol: LOC112231469
3 Cross references
209 Possible Orthologues:

60s Ribosomal Protein L24

Ensembl ID : ENSOTSG00005012739
Gene Symbol: LOC112225340
3 Cross references
311 Possible Orthologues:

60s Ribosomal Protein L28-Like

Ensembl ID : ENSOTSG00005023347
Gene Symbol: LOC112219702
3 Cross references
279 Possible Orthologues:

60s Ribosomal Protein L3

Ensembl ID : ENSOTSG00005030729
Gene Symbol: LOC112234092
3 Cross references
331 Possible Orthologues:

60s Ribosomal Protein L3

Ensembl ID : ENSOTSG00005041174
Gene Symbol: LOC112234092
3 Cross references
331 Possible Orthologues:

60s Ribosomal Protein L30

Ensembl ID : ENSOTSG00005019207
Gene Symbol: LOC112229383
3 Cross references
403 Possible Orthologues:

60s Ribosomal Protein L34

Ensembl ID : ENSOTSG00005001667
Gene Symbol: LOC112260120
3 Cross references
356 Possible Orthologues:

60s Ribosomal Protein L35

Ensembl ID : ENSOTSG00005047731
Gene Symbol: LOC112220058
3 Cross references
265 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).